Navigation Links
New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
Date:5/15/2008

E450a

metastatic colorectal cancer: First

BEAT

Berry S, et al, Abstract No. 4025,

Poster No. 12.

Avastin The safety of long-term bevacizumab Monday 2 June 2008,

use: Results from the BRiTE 8:00am - 12:00pm, S

observational cohort study (OCS). Hall A1

Purdie D, et al, Abstract No. 4103,

Poster No. 14G

Avastin Safety and effectiveness of Sunday 1 June 2008,

bevacizumab (BV) and chemotherapy 8:00am - 12:00pm,

(CT) in elderly patients (pts) with E450a

metastatic colorectal cancer (mCRC):

Results from the BRiTE observational

cohort study. Kozloff M, et al,

Abstract N0. 4026, Poster No. 13

Full details of key Roche data presentations will be available on Friday 30th May at an invitation-only media event for non-US journalists. All abstracts are available at: http://www.asco.org/ASCO/Meetings .

Editor's note

-- Breast Cancer is one of the most common types of cancer in women, eight

to nine percent of women will develop this cancer during their

lifetime(1). Each year more than one million new cases of breast

cancer are diagnosed(2) with a death rate of over 500,000 people per

year.(3)

-- Avastin doubles the chance of a patient living without their disease

advancing (progression free survival). When used in combination with

taxanes (chemotherapy), Avastin substantially increases the efficacy of

treatment with limited impact on safety. Studies show that continual

direct VEGF inhibition with Avastin maximizes the treatment benefit for

the patient.

-- Herceptin is a humanised antibody sp
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
3. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
4. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
5. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
6. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
7. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
8. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
9. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
10. Roche responds to announcement of IDEAL hepatitis C trial results
11. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)...  Misonix, Inc. (NASDAQ: MSON ), an ... markets innovative therapeutic ultrasonic products for spine surgery, ... surgery and other surgical applications, announced today that ... quarter fiscal year 2015 on Thursday, May 7, ... that same day, Thursday, May 7, 2015, at ...
(Date:5/1/2015)... N.J., May 1, 2015 Cambrex Corporation (NYSE: ... 31, 2015. Highlights , Sales ... increased 27% excluding foreign currency impact, driven by Innovator products ... from $8.4 million in the first quarter of 2014. ... $0.04 in the first quarter last year and Adjusted Diluted ...
(Date:4/30/2015)... 30, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: ... a focus on Omega-3 therapies for cardiovascular disease ... and financial results for the fiscal year ended ... are in Canadian dollars unless otherwise stated. ... with the right strategic partners and additional capitalization ...
Breaking Medicine Technology:Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2Cambrex Reports First Quarter 2015 Financial Results 2Cambrex Reports First Quarter 2015 Financial Results 3Cambrex Reports First Quarter 2015 Financial Results 4Cambrex Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 6Cambrex Reports First Quarter 2015 Financial Results 7Cambrex Reports First Quarter 2015 Financial Results 8Cambrex Reports First Quarter 2015 Financial Results 9Cambrex Reports First Quarter 2015 Financial Results 10Cambrex Reports First Quarter 2015 Financial Results 11Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6
... 25, 2011 Angelini Labopharm, LLC, today ... Company.  Formerly Senior Vice President, Sales and Marketing for ... subsidiary, Labopharm USA, Inc., Ms. Heino,s primary focus will ... the commercialization of OLEPTRO™, as well as to explore ...
... N.J., Jan. 25, 2011 Johnson & Johnson (NYSE: ... the fourth quarter of 2010, a decrease of 5.5% as ... 5.1% and the negative impact of currency was 0.4%. Domestic ... operational decline of 2.3% and a negative currency impact of ...
Cached Medicine Technology:Angelini Labopharm Confirms Appointment of Mary Anne Heino as President 2Angelini Labopharm Confirms Appointment of Mary Anne Heino as President 3Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 2Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 3Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 4Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 5Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 6Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 7Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 8Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 9Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 10Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 11Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 12Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 13Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 14
(Date:5/3/2015)... CA (PRWEB) May 03, 2015 NuevaCare ... MnemeTherapy® at two upcoming area seminars. The first event ... PSA Annual Regional Stroke Conference to be held at ... offered on Wednesday, May 13 during the Dementia Conference ... , “These seminars offer an excellent opportunity to ...
(Date:5/3/2015)... 2015 HealthPostures, a pioneering ergonomics ... its appearance at the , May 5 - 7, ... will exhibit at the conference include its bestselling TaskMate ... solutions is the 6100 TaskMate Executive. Features of the ... adjustable keyboard tray, extended platform work surface and supply ...
(Date:5/2/2015)... BC (PRWEB) May 02, 2015 Vancouver fencing ... will now provide valuable advice to prospective clients related to ... are looking to install railings around their decks and patios. ... several questions that pop up once the person rolls up ... phases of installing a railing in finding a gate that ...
(Date:5/2/2015)... York, NY (PRWEB) May 02, 2015 ... when a deadly natural disaster strikes anywhere on this ... to leverage human sympathy and compassion for their own ... (United States Computer Emergency Readiness Team) issued an ... users “of potential email scams citing the earthquake in ...
(Date:5/2/2015)... On Tuesday April 7th, the patient ... to celebrate improvements in patient care. In 2014 the ... had zero acquired ventilator associated infections, zero central line ... was also recently named a Top Performer by the ... credited the teamwork of staff from all departments involved ...
Breaking Medicine News(10 mins):Health News:NuevaCare Introduces MnemeTherapy® Approach to Care for Elderly Patients with Alzheimer’s, Stroke and Other Types of Neurodegenerative Conditions 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2
... An elevated rate of increase in prostate specific antigen (PSA) ... prostate cancer, according to a new study published in the ... rate of PSA increase prior to treatment (PSA Velocity) is ... high risk of death from prostate cancer. ,According ...
... A ten-day long festival for gays began in the capital ... will showcase over 20 films on homosexuality directed by many ... and a photographic presentation. ,The aim of the ... country where Section 377 of the Indian Penal Code (IPC) ...
... has adopted yet another spiritual ploy to keep her out of ... report to Los Angeles' Century Regional Detention Center by June 5, ... Mary. ,In the past few days Paris has been ... DVD called Innocent. ,Some pals feel that Hilton, who ...
... chemotherapy errors identified in children reach patients, according to ... errors in children . Published in the July 1, ... American Cancer Society, the study concluded that the antimetabolite ... errors, and that errors in drug administration and errors ...
... UK have discovered mutations in the DNA of four ... breast cancer in women . ,The discovery ... at higher-than-average risk of breast cancer so that they ... - the age when routine breast screening now begins. ...
... participating in one of the largest ever Parkinson's disease ... creatine can slow the symptom progression of this ... the brain in which patients develop tremor, slowness of ... one million people in the U.S. Currently, there are ...
Cached Medicine News:Health News:Scientists Identify the Most Significant Single Predictor of Aggressive Prostate Cancer 2Health News:Gay Film Festival Begins in Delhi 2Health News:Most Pediatric Chemotherapy Mistakes Reach Patients 2Health News:UK Scientists Identify Gene Mutations That Trigger Breast Cancer 2Health News:UK Scientists Identify Gene Mutations That Trigger Breast Cancer 3Health News:Emory Participates in Study to Slow Progression of Parkinson's Disease 2
... feature powerful, maintenance-free motors, and ... rotors for unparalleled application versatility. ... one: a high capacity general ... a high-speed centrifuge for separating ...
... Rotor has a standard 1.5ml rotor and 6 ... Easy operation (no switches to mess with). Simply ... the plastic tab to open. Starts and stops ... 2000 x g. Only five inches in diameter. ...
... Personal Micro Centrifuges MiniSpin and MiniSpin plus ... they are powerful enough so that each ... centrifuge for a wide range of molecular ... are available to meet your performance requirements. ...
Spectrafuge 16M High speed microcentrifuge. High g-force for molecular biology applications. Brushless, maintenance-free motor. Easy to use control panel. Complete with 18 x 1.5/2.0 ml rotor. StripSp...
Medicine Products: